Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP382543.RAeAtnM1W_OFLWcOb-zeCd0o20u-_Cr4Rtl4iPtzeT1cE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP382543.RAeAtnM1W_OFLWcOb-zeCd0o20u-_Cr4Rtl4iPtzeT1cE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP382543.RAeAtnM1W_OFLWcOb-zeCd0o20u-_Cr4Rtl4iPtzeT1cE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP382543.RAeAtnM1W_OFLWcOb-zeCd0o20u-_Cr4Rtl4iPtzeT1cE130_provenance.
- NP382543.RAeAtnM1W_OFLWcOb-zeCd0o20u-_Cr4Rtl4iPtzeT1cE130_assertion description "[A series of 12 organic arsonic acid compounds has been synthesized and evaluated against human B-lineage (NALM-6) and T-lineage (MOLT-3) acute lymphoblastic leukemia (ALL) cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382543.RAeAtnM1W_OFLWcOb-zeCd0o20u-_Cr4Rtl4iPtzeT1cE130_provenance.
- NP382543.RAeAtnM1W_OFLWcOb-zeCd0o20u-_Cr4Rtl4iPtzeT1cE130_assertion evidence source_evidence_literature NP382543.RAeAtnM1W_OFLWcOb-zeCd0o20u-_Cr4Rtl4iPtzeT1cE130_provenance.
- NP382543.RAeAtnM1W_OFLWcOb-zeCd0o20u-_Cr4Rtl4iPtzeT1cE130_assertion SIO_000772 12565976 NP382543.RAeAtnM1W_OFLWcOb-zeCd0o20u-_Cr4Rtl4iPtzeT1cE130_provenance.
- NP382543.RAeAtnM1W_OFLWcOb-zeCd0o20u-_Cr4Rtl4iPtzeT1cE130_assertion wasDerivedFrom befree-2016 NP382543.RAeAtnM1W_OFLWcOb-zeCd0o20u-_Cr4Rtl4iPtzeT1cE130_provenance.
- NP382543.RAeAtnM1W_OFLWcOb-zeCd0o20u-_Cr4Rtl4iPtzeT1cE130_assertion wasGeneratedBy ECO_0000203 NP382543.RAeAtnM1W_OFLWcOb-zeCd0o20u-_Cr4Rtl4iPtzeT1cE130_provenance.
- befree-2016 importedOn "2016-02-19" NP382543.RAeAtnM1W_OFLWcOb-zeCd0o20u-_Cr4Rtl4iPtzeT1cE130_provenance.